Biomedical Engineering Reference
In-Depth Information
27. Falls, D.L., Neuregulins: functions, forms, and signaling strategies.
Exp
Cell Res
, 2003.
284
(1): 14-30.
28. Ozcelik, C.,
, Conditional mutation of the ErbB2 (HER2) receptor
in cardiomyocytes leads to dilated cardiomyopathy.
et al.
Proc Natl Acad Sci
U S A
, 2002.
99
(13): 8880-8885.
29. Liu, F.F.,
, Heterozygous knockout of neuregulin-1 gene in mice
exacerbates doxorubicin-induced heart failure.
et al.
Am J Physiol Heart Circ
(2): H660-H666.
30. Bird, B.R., and S.M. Swain, Cardiac toxicity in breast cancer survivors:
review of potential cardiac problems.
Physiol
, 2005.
289
Clin Cancer Res
, 2008.
14
(1):
14-24.
31. Bargmann, C.I., M.C. Hung, and R.A. Weinberg, Multiple independent
activations of the neu oncogene by a point mutation altering the
transmembrane domain of p185.
(5): 649-657.
32. Bargmann, C.I., and R.A. Weinberg, Oncogenic activation of the neu-
encoded receptor protein by point mutation and deletion.
Cell
, 1986.
45
EMBO J
,
(7): 2043-2052.
33. Muller, W.J.,
1988.
7
, Single-step induction of mammary adenocarcinoma
in transgenic mice bearing the activated c-neu oncogene.
et al.
Cell
, 1988.
(1): 105-115.
34. Guy, C.T.,
54
, Expression of the neu protooncogene in the mammary
epithelium of transgenic mice induces metastatic disease.
et al.
Proc Natl
Acad Sci U S A
, 1992.
89
(22): 10578-10582.
35. Siegel, P.M.,
, Novel activating mutations in the neu proto-oncogene
involved in induction of mammary tumors.
et al.
Mol Cell Biol
, 1994.
14
(11):
7068-7077.
36. Andrechek, E.R.,
, Amplification of the neu/erbB-2 oncogene in
a mouse model of mammary tumorigenesis.
et al.
Proc Natl Acad Sci U S A
,
(7): 3444-3449.
37. Lemoine, N.R.,
2000.
97
, Absence of activating transmembrane mutations
in the c-erbB-2 proto-oncogene in human breast cancer.
et al.
Oncogene
,
1990.
5
(2): 237-239.
38. Zoll, B.,
et al.
, Alterations of the c-erbB2 gene in human breast cancer.
J
Cancer Res Clin Oncol
, 1992.
118
(6): 468-473.
39. Chazin, V.R.,
, Transformation mediated by the human HER-2 gene
independent of the epidermal growth factor receptor.
et al.
Oncogene
, 1992.
7
(9): 1859-1866.
